Ultimate Products Plc (ULTP.L)
GBp 115.5
(-0.43%)
GBp 115.5
(-0.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 14.18 Million | 19.25 Million | 3.68 Million | 8.62 Million | 14.82 Million | 3.92 Million |
| Net Income | 10.52 Million | 12.58 Million | 12.37 Million | 7.31 Million | 6.61 Million | 6.41 Million |
| Depreciation & Amortization | 2.19 Million | 2.24 Million | 2.06 Million | 1.57 Million | 1.42 Million | 1.52 Million |
| Deferred income taxes | 118 Thousand | - | - | - | 24 Thousand | 21 Thousand |
| Stock-based compensation | - | 837 Thousand | 403 Thousand | 228 Thousand | 267 Thousand | - |
| Change in working capital | 334 Thousand | 4.34 Million | -12.14 Million | 572 Thousand | 6.86 Million | -4.91 Million |
| Other non-cash items | 1.01 Million | 225 Thousand | 17.66 Million | 1.74 Million | -4.11 Million | 8.85 Million |
| Investing Cash Flow | -1.3 Million | -1.98 Million | -3.8 Million | -32.94 Million | -589 Thousand | -702 Thousand |
| Investments in PPE | -1.3 Million | -999 Thousand | -1.84 Million | -2.37 Million | -601 Thousand | -720 Thousand |
| Acquisitions | - | -987 Thousand | -1.96 Million | -30.57 Million | 12 Thousand | 18 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -13.26 Million | -18.38 Million | 6.18 Million | 24.13 Million | -14.02 Million | -3.19 Million |
| Debt repayment | -4.86 Million | -10.75 Million | -11.58 Million | -14.9 Million | -10.43 Million | -1.64 Million |
| Dividends payments | -6.41 Million | -6.25 Million | -4.83 Million | -4.4 Million | -2.3 Million | -2.42 Million |
| Common Stock Repurchased | -1.14 Million | -532 Thousand | - | - | -506 Thousand | -1.64 Million |
| Common Stock Issuance | - | - | 373 Thousand | 14.35 Million | - | - |
| Other Financing Activities | -838 Thousand | -2.08 Million | - | - | - | - |
| Accounts receivables | -207 Thousand | 2.69 Million | -5.64 Million | -8.09 Million | 150 Thousand | -3.93 Million |
| Accounts payables | 9.04 Million | 559 Thousand | 1.22 Million | 9.03 Million | 2.33 Million | 2.94 Million |
| Inventory | -8.5 Million | 1.09 Million | -7.72 Million | -368 Thousand | 4.37 Million | -3.93 Million |
| Other working capital | - | 559 Thousand | - | - | - | - |
| Cash at beginning of period | 5.08 Million | 6.2 Million | 133 Thousand | 329 Thousand | 122 Thousand | 95 Thousand |
| Cash at end of period | 4.73 Million | 5.08 Million | 6.2 Million | 133 Thousand | 329 Thousand | 122 Thousand |
| Capital Expenditure | -1.3 Million | -999 Thousand | -1.84 Million | -2.37 Million | -601 Thousand | -720 Thousand |
| Effect of forex changes on cash | - | -1000.00 | 4000.00 | -5000.00 | -5000.00 | - |
| Net cash flow / Change in cash | -353 Thousand | -1.11 Million | 6.06 Million | -196 Thousand | 207 Thousand | 27 Thousand |
| Free Cash Flow | 12.88 Million | 18.25 Million | 1.83 Million | 6.25 Million | 14.22 Million | 3.2 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.11 Million | 5.3 Million | 12.58 Million | 7.28 Million | 12.37 Million | 4.75 Million |
| Depreciation & Amortization | 1.06 Million | 1.1 Million | 2.24 Million | 1.13 Million | 2.06 Million | 1.08 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 837 Thousand | - | 403 Thousand | - |
| Change in working capital | 3.02 Million | 2.76 Million | 4.34 Million | 1.57 Million | -12.14 Million | 4.27 Million |
| Other non-cash items | -15 Thousand | -1.18 Million | 225 Thousand | 1.41 Million | 17.66 Million | -1.64 Million |
| Investing Cash Flow | -654 Thousand | -1.13 Million | -1.98 Million | -855 Thousand | -3.8 Million | -2.67 Million |
| Investments in PPE | -654 Thousand | -637 Thousand | -999 Thousand | -362 Thousand | -1.84 Million | -1.2 Million |
| Acquisitions | - | -494 Thousand | -987 Thousand | -493 Thousand | -1.96 Million | -1.46 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -10.74 Million | -7.32 Million | -18.38 Million | -11.05 Million | 6.18 Million | -1.96 Million |
| Debt repayment | -6.14 Million | -4.57 Million | -10.75 Million | -6.17 Million | -11.58 Million | -88 Thousand |
| Dividends payments | -4.28 Million | -2.09 Million | -6.25 Million | -4.15 Million | -4.83 Million | -1.98 Million |
| Common Stock Repurchased | - | -234 Thousand | -532 Thousand | -298 Thousand | - | - |
| Common Stock Issuance | 135 Thousand | - | - | - | 373 Thousand | 373 Thousand |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 4.59 Million | 4.82 Million | 2.69 Million | -2.12 Million | -5.64 Million | 5.55 Million |
| Accounts payables | -288 Thousand | -1.27 Million | 559 Thousand | 1.83 Million | 1.22 Million | 1.02 Million |
| Inventory | -1.28 Million | -782 Thousand | 1.09 Million | 1.87 Million | -7.72 Million | -2.3 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 5.08 Million | 5 Million | 6.2 Million | 6.2 Million | 133 Thousand | 257 Thousand |
| Cash at end of period | 5.78 Million | 5.08 Million | 5.08 Million | 5 Million | 6.2 Million | 6.2 Million |
| Capital Expenditure | -654 Thousand | -637 Thousand | -999 Thousand | -362 Thousand | -1.84 Million | -1.2 Million |
| Effect of forex changes on cash | - | - | -1000.00 | - | 4000.00 | - |
| Net cash flow / Change in cash | 694 Thousand | 82 Thousand | -1.11 Million | -1.19 Million | 6.06 Million | 5.94 Million |
| Free Cash Flow | 11.41 Million | 7.9 Million | 18.25 Million | 10.34 Million | 1.83 Million | 9.37 Million |
GULFNAV
AARTIPHARM
SELAN
SQI
300347
000738